HELP
How you can help DNDi?
To develop seven new treatments by 2014, DNDi needs to raise 255 million euros from governments, foundations, companies, and private individuals.

To find out how to support one short-tem project, a part of the portfolio of projects for a specific disease, or the initiative itself, please contact:

Jana Armstrong
Fundraising Manager
+41.22.906.9240

supportdndi@dndi.org

DNDi is a not-for-profit drug development initiative established in 2003 by four publicly-funded research organisations - Kenya Medical Research Institute, Indian Council for Medical Research, Oswaldo Cruz Foundation Brazil, Malaysian Ministry of Health; a private research institute, the Institut Pasteur; an international research organisation WHO's Tropical Diseases Research programme; and an international humanitarian organisation Médecins Sans Frontières.

DNDi aims to develop new, improved and field-relevant drugs for neglected diseases such as leishmaniasis, human African trypanosomiasis, and Chagas disease that afflict the very poor in developing countries. It will raise awareness of the urgent need to develop drugs for these diseases and use DNDi projects to strengthen existing capacity in disease-endemic countries.
Published by Drugs for Neglected Diseases Initiative - 1 Place St Gervais 1201 Geneva Switzerland - Photo credits: DNDi
Editor: Ann-Marie Sevcsik - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 - www.dndi.org